Stock Analysis, Dividends, Split History

SNBP / Sun BioPharma, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price3.00
Volume4,300.00
Market Cap ($M)15.18
Enterprise Value ($M)14.58
Book Value ($M)0.11
Book Value / Share0.02
Price / Book138.02
NCAV ($M)0.06
NCAV / Share0.01
Price / NCAV276.03
Share Statistics
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 3,841,652
Common Shares Outstanding 4,093,852
Scoring Models
Piotroski F-Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)3.06
Return on Assets (ROA)-11.83
Return on Equity (ROE)2.23
Balance Sheet (mrq) ($M)
Assets1.55
Liabilities1.44
Quick Ration/a
Current Ratio1.04
Income Statement (mra) ($M)
Service Revenue Related Party0.00
Revenues0.00
Sales Revenue Net0.00
Operating Income-6.02
Net Income-10.37
Earnings Per Share Basic And Diluted-2.91
Cash Flow Statement (mra) ($M)
Cash From Operations-3.40
Identifiers and Descriptors
CUSIP82935Y103
Central Index Key (CIK)1029125

Split History

Stock splits are used by Sun BioPharma, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
CUSIP: 82935Y103